Primary Sclerosing Cholangitis clinical trials at UCSF
1 in progress, 1 open to new patients
Safety, Tolerability, and Efficacy of GS-9674 in Adults With Primary Sclerosing Cholangitis Without Cirrhosis
open to eligible people ages 18–70
The primary objective of this study is to evaluate the safety and tolerability of GS-9674 in adults with primary sclerosing cholangitis (PSC).
San Francisco, California and other locations